Pharmacology of Local Anesthetic in Dentistry

Pharmacology of Local Anesthetics
in Dentistry
Outline
1. Brief Introduction and structure
2. Dental Local Anesthetic Drugs
3. Vasoconstrictors and other additives
4. Topical Anesthetics
5. Dose Calculations
6. Relative Analgesia
Brief Introduction
All Local Anesthetics are:
Weak Bases
Unstable
Have an acidic pH to maximise their water
solubility and chemical stability - increases
shelf-life
Poorly water soluble in un-ionized state
Have lipophilic and hydrophilic ends
Functional characteristics determined by the
dissociation constant (pKa ), lipid
solubility, and protein binding.
Structure
R3NH + HCl -> R3NH+ + Cl-

Functional Characteristics
1. Dissociation constant (pKa ): How easy ions dissociate
The closer the LAs pKa to the bodys pH, the faster the onset
Most local anesthetics have a pKa greater than 7.4. Because the neutral base
form of the local anesthetic (R3N) is more lipophilic, can penetrate nerve
membranes faster. As the pKa of a local anesthetic rises, the percentage in the
ionized form (R3NH+) increases and onset of the block slows
2. Lipid solubility
3. Protein binding.
Functional Characteristics
1. Dissociation constant (pKa)
2. Lipid solubility
Solubility Ability to penetrate connective tissue and cell membranes
Potency
3. Protein binding
Affinity for protein binding Time bound to nerve membranes
Duration of action
Types of LAs used in Dentistry We usually use:
1.Xylestesin A (2% lidocaine

hydrochloride, adrenaline 1:80.000)
2. Mepivastesin (3% Mepivacaine)
Vasoconstrictors
Reduce blood flow at site of injection, reducing the spread of LA, hence
increasing duration
Delays the absorption which decreases chance of systemic toxicity
Two types are used
1. Adrenaline: Effective vasoconstrictor, Contraindication: Heart Disease

2. Felypressin: Less effective, slower onset, minimal effect on the heart
Other Additives
1. Preservative: Prevent oxidation of vasoconstrictor
2. Bicarbonate: Speed of onset of anaesthesia is increased
3. Opioids: Enhance and prolong LAs effect
4. Glucose: To increase baricity
Alkalinisation
- To be added immediately before
injection
- May result in less stinging pain being
experienced by the patient
- More rapid drug diffusion and a quicker
onset of nerve blocking
- Has to be added carefully - precipitation
Routes of Uptake
1) Oral route
Hepatic first pass effect (72% lignocaine)
2) Topical (Can be used in case of problem statement)
Mucosa
3) Injection
Vascularity of target site
Vasoactivity of drug
Topical Anesthetics
Potentially more toxic than injectable LA
Inadequate methods for determining doses (esp. Liquid, gel, unmetered
sprays)
Penetrates the mucous membrane / tissue Superficial nerves
Depth: 2-3mm
Reduce pain of injection (except ID block)
Esp. max. lingual injection medial to 1st molar
Topical Anesthetics
Common forms
Liquid rinses Less site-specific
Gels Useful in smaller areas Cotton swabs
Metered / unmetered sprays
Application of refrigerant Faster
Oral cavity patches
Subgingival liquid-to-gel system Cartridge form Easy quantified volume
etc
Common Topical Agents
1) Benzocaine
2) Dyclonine
3) Lidocaine
4) Tetracaine
5) Butamben (ONLY in mixture)
6) Eutectic mixture
Lidocaine
5% ointment, gel, liquid

10% metered spray
Onset: 1-2min
Benzocaine
14-20% liquid, gel

Onset: 30s
Lower toxicity
Recommended for pedo
May induce methemoglobinemia
Dyclonine
Dyclonine hydrochloride
Ketone
Safe, durable
Bactericidal & fungicidal
Dose Calculations (Recap)
Bioavailability (F)
Extent of absorption
For i.v. injection F=1
F = AUC x CL / Dose
Volume of Distribution (Vd)
Apparent volume distributed by drug

Vd = Dose / Ct
Half-life (t1/2)
Time taken for [drug] in plasma to be reduced by half

t1/2 = ln2 / k
Drug Clearance (CL)
Efficiency of drug removal

CL = Vd x k
Loading Dose
Dose(s) given at the onset to achieve target conc. rapidly

Loading dose = Target Cp x Vd / F
Maintenance Dose
Drug administration to maintain steady-state conc.

Dosing rate = Target Cp x CL / F
Dose Calculations
Other necessary information
Concentration for anesthetic drug

Standard cartridge volumes
Dilution percentages for vasoconstrictors
Defined MRD
Dose Calculations
Drug Concentration
Drug percentage (Relative amount in cartridge)

No. of grams in 100mL of solution
100% = 1000mg / mL
10% = 100mg / mL
Dose Calculations
Dose Calculations
Case: 1% lidocaine, 1.7mL / cart
For healthy adult, MRD = 3.2mg/lbs or 7mg/kg
Maximum recommended dose = 7 x weight in kg
Maximum no. of cart = 7 x weight / (10 x 1.7)

Dose Calculations
Standard North American cartridge = 1.8 mL (1.8 cc)
1 cartridge of 1 % LA = 10mg/mL x 1.8mL/cart = 18mg/cart
Sometimes: 1.7 mL / others
Example: Two cartridges of 2% lidocaine administered to 100-lb patient
Drug administered = 2 (cartridges) x 36mg = 72mg
MRD = 3.2mg/lb x 100lb = 320mg
Additional dose = 320 - 72 = 248mg
No. of additional cartridge = 248 / 36 = 6.8 cart

Dose Calculations
Vasoconstrictor dose
Dilution ratios
MRD is NOT dependent of weight
Expressed as mg/mL(or cc)
Example
1:1,000 = 1g / 1000mL = 1mg / 1mL
In standard cartridge 1.8mg / cart
1:20,000 / 1:50,000 / 1:100,000 / 1:200,000

Dose Calculations
Limiting drug
Example: 2% lidocaine, 1:100,000 epinephrine administered to patient of 150lbs
Max. (lidocaine) = 3.2 x 150 = 480mg = ~13 cart
Max. (epinephrine) = 0.2 / 0.018 = ~11 cart
In this case Epinephrine is limiting drug
Cardiac dose
0.04mg for epinephrine & 0.2mg for levonordefrin

Dose Calculations
Paediatric doses
Example: 2% lidocaine for 50-lb child, MRD = 2mg/lb
Clarks Rule
Weight
Divided by 150 Fraction of adult dose to child
Similar to weight x MRD for children
2 x 150 x (50 / 150) = 100mg OR 2 x 50 = 100mg
Youngs Rule
Age
Adult dosage x childs age / (12 + childs age)
300 x 6 / (12 + 6) = 100mg
Relative Analgesia (RA)
Drug administration Reduce pain perception
Inhalation sedation / laughing gas / nitrous oxide-oxygen
Conscious but may have loss of memory of treatment
Nitrous oxide
Rapid saturation (5min) & elimination (90% in 10min)
Subject in problem statement
Relative Analgesia
Four levels
1) Tingling sensation / feeling of vibration (6-25%)
2) Warm sensation / feeling of drunk (25-45%)
3) Loss of ability to respond (46-65%)
4) Sleepiness / dream (66-80%)
Light / non-fatty meal
Increment of 10% nitrous oxide / 1min (NOT exceeding 50%)
Desired mix is fed through tube to nasal hood Breathing
Double-mask
Relative Analgesia
Adv
Works rapidly Reaches brain within 20s, relaxation & pain-killing after 2 or
3 min
Depth of sedation can be adjusted from time to time
Varying duration of action
No hangover Rapid elimination
No injection
Few side effects
Relative Analgesia
Disadv
NOT suitable for patients with airway problems / chemotherapy / pregnant

women
NOT enough sedation for some with permissible oxygen level
NOT common in many dental clinics
Trained staff / bulky & costly equipment
Possible health risks
END

Pharmacology of Local Anesthetic in Dentistry

Uploaded by

Copyright:

Available Formats

Pharmacology of Local Anesthetic in Dentistry

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Pharmacology of Local Anesthetic in Dentistry

Uploaded by

Copyright:

Available Formats

Pharmacology of Local Anesthetics

R3NH + HCl -> R3NH+ + Cl-

Solubility Ability to penetrate connective tissue and cell membranes

Affinity for protein binding Time bound to nerve membranes

1.Xylestesin A (2% lidocaine

Two types are used

1. Adrenaline: Effective vasoconstrictor, Contraindication: Heart Disease

5% ointment, gel, liquid

14-20% liquid, gel

Volume of Distribution (Vd)

Apparent volume distributed by drug

Time taken for [drug] in plasma to be reduced by half

Drug Clearance (CL)

Efficiency of drug removal

Dose(s) given at the onset to achieve target conc. rapidly

Drug administration to maintain steady-state conc.

Concentration for anesthetic drug

Drug percentage (Relative amount in cartridge)

For healthy adult, MRD = 3.2mg/lbs or 7mg/kg

Maximum recommended dose = 7 x weight in kg

Maximum no. of cart = 7 x weight / (10 x 1.7)

Example: Two cartridges of 2% lidocaine administered to 100-lb patient

Drug administered = 2 (cartridges) x 36mg = 72mg

MRD = 3.2mg/lb x 100lb = 320mg

Additional dose = 320 - 72 = 248mg

No. of additional cartridge = 248 / 36 = 6.8 cart

1:1,000 = 1g / 1000mL = 1mg / 1mL

In standard cartridge 1.8mg / cart

1:20,000 / 1:50,000 / 1:100,000 / 1:200,000

Example: 2% lidocaine, 1:100,000 epinephrine administered to patient of 150lbs

Max. (lidocaine) = 3.2 x 150 = 480mg = ~13 cart

Max. (epinephrine) = 0.2 / 0.018 = ~11 cart

In this case Epinephrine is limiting drug

0.04mg for epinephrine & 0.2mg for levonordefrin

Example: 2% lidocaine for 50-lb child, MRD = 2mg/lb

NOT suitable for patients with airway problems / chemotherapy / pregnant

You might also like